Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
20 Mar 2015

ESMO 2014: Tumour evolution and precision medicine

At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how understanding the genetic changes in tumour evolution…
EMJ
20 Mar 2015

ESMO 2014: Tumour evolution and proactive clinical management

At ESMO 2014, Prof Charles Swanton (London Research Institute and UCL, London, UK) discusses how we can begin to anticipate tumour evolutionary…
EMJ
16 Mar 2015

ESMO 2014: The collaboration between UCL and the Francis Crick Institute

At ESMO 2014, Prof Jonathan Ledermann (UCL, UK) discusses the collaboration between UCL and the Francis Crick Institute that is hoped to increase the…
EMJ
16 Mar 2015

ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management

At ESMO 2014, Prof Jonathan Ledermann (University College London, UK) provides an update on the management of ovarian cancer, including maintenance…
EMJ
17 Feb 2015

ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma

Dr Andrew Davies (University of Southampton, Southampton, UK) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses a phase II/III…
EMJ
12 Feb 2015

The role of nurses for supporting patients with myeloma

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Monica Morris, Healthcare Professional Programme Manager, Myeloma UK…
EMJ
9 Feb 2015

Adjuvant chemotherapy use in breast cancer after introducing the Oncotype DX® Breast Cancer Assay

The Oncotype DX® Breast Cancer Assay, a multigene assay, stratifies breast cancer patients into groups that are at low, intermediate or high risk for…